Top Injectable Manufacturer in Haiti – Reliable Pharmaceutical Solutions
- Maulik Sudani
- 3 days ago
- 8 min read
Last Updated: August 23, 2026
TL;DR: Haiti regulates medicines through the Direction de la Pharmacie, du Médicament et de la Médecine Traditionnelle (DPM/MT), part of the Ministère de la Santé Publique et de la Population (MSPP), which requires sanitary registration for every imported pharmaceutical product — a dossier covering clinical, toxicological and manufacturing-certificate documentation from the country of origin, plus physical product samples — alongside a separate import permit from the Ministry of Commerce and Industry. Haiti is not a Hague Apostille Convention member, so Certificates of Pharmaceutical Product and GMP certificates from India must go through full consular/embassy legalization rather than the faster apostille route. Haiti's health landscape has been severely strained since 2024: gangs control an estimated 80-90% of Port-au-Prince, a September 2024 attack shut down operations at the capital's main port terminal, and a resurgent cholera epidemic has spread nationwide; by February 2025 only around 10% of health facilities were reported fully operational, and Cap-Haïtien in the north has become the country's main functioning port-and-airport gateway. Maternal mortality remains among the highest in the Americas, near 350 per 100,000 live births. Farbe Firma, a WHO-GMP certified sterile injectable manufacturer in Gujarat, India producing 100+ injectable products under ISO Class 5 aseptic conditions and exporting to 30+ countries, supports Haitian importers and humanitarian partners with CTD/ACTD-ready documentation adapted to this exceptionally difficult operating environment.
Key Takeaways
Haiti's Direction de la Pharmacie, du Médicament et de la Médecine Traditionnelle (DPM/MT), operating under the Ministère de la Santé Publique et de la Population (MSPP), requires sanitary registration for every pharmaceutical product entering the country — a dossier that includes clinical study information, toxicology data and pharmaceutical certification from the country of origin, plus physical samples of each product, before MSPP issues a favorable opinion. A separate import permit must also be obtained from the Ministry of Commerce and Industry, and Farbe Firma prepares its documentation to satisfy both requirements together.
We could not confirm a current, published WHO Global Benchmarking Tool maturity level for Haiti's regulatory system and have not stated one here. Haiti is not a Hague Apostille Convention member, so Certificates of Pharmaceutical Product and GMP certificates from India require full consular/embassy legalization through the Haitian diplomatic chain rather than a faster apostille, even though India itself has been an apostille member since 2005.
Since 2024, gangs have come to control an estimated 80-90% of Port-au-Prince, and a September 25, 2024 attack on the capital's main port terminal looted containers, damaged infrastructure and halted operations; road blockades and closed distribution centers have since worsened medicine shortages nationwide, and Doctors Without Borders reported only around 10% of health facilities fully operational by February 2025. Cap-Haïtien International Airport, roughly 136km north of the capital and paired with a seaport just 5km away, became the country's sole operating international airport in March 2025 and now functions as Haiti's main safer commercial gateway, served by carriers including King Ocean and Antillean.
A cholera epidemic has been resurging across Haiti since mid-2024, worsened by fuel shortages that have disrupted water-treatment and outbreak-response efforts, and case counts are widely believed to be undercounted, particularly in gang-controlled areas. Maternal mortality remains among the highest in the Americas — around 350 per 100,000 live births in the most recent PAHO estimate, with 846 maternal deaths reported in 2023 alone — keeping injectable oxytocics and antibiotics in constant demand.
Introduction: Why an Injectable Manufacturer in Haiti Must Meet Global Standards
Haiti presents one of the most difficult operating environments in this entire series. A near-total dependence on imported medicines meets a security and logistics crisis severe enough that, by early 2025, international humanitarian organizations were reporting only around one in ten health facilities nationwide fully operational. In a market like this, the question for any injectable manufacturer in Haiti is not just whether a product meets specification on paper, but whether the manufacturer can document quality rigorously enough to satisfy MSPP's sanitary registration process and, just as importantly, whether supply can realistically reach patients given the state of the country's ports, roads and distribution networks.
Farbe Firma Pvt Ltd, operating from Gujarat, India as a WHO-GMP certified sterile injectable manufacturer, produces more than 100 injectable formulations inside ISO Class 5 aseptic filling suites and exports to more than 30 countries under CTD and ACTD dossier formats. Being a dependable partner for Haiti means accepting that the country is not a Hague Apostille Convention member, so certificate legalization takes longer than in most of the markets we serve, and that routing through Port-au-Prince can no longer be assumed given the port disruptions and gang control that have defined the capital since 2024. Farbe Firma builds its Haiti engagement around that reality rather than around how the market looked before 2024.
What Sets a World-Class Injectable Manufacturer in Haiti Apart
Any credible injectable manufacturer in Haiti has to work through the Direction de la Pharmacie, du Médicament et de la Médecine Traditionnelle (DPM/MT), the branch of the Ministère de la Santé Publique et de la Population (MSPP) responsible for medicine registration. Every pharmaceutical product requires sanitary registration before import, supported by a dossier of clinical study information, toxicology data and a pharmaceutical certificate from the country of origin, along with physical product samples submitted for review; MSPP must then issue a favorable opinion before the product can move forward. A separate import permit from the Ministry of Commerce and Industry is also required, and Farbe Firma's regulatory team prepares both tracks of documentation together rather than treating them as sequential afterthoughts.
We have not found a current, publicly confirmed WHO Global Benchmarking Tool maturity classification for Haiti's regulatory system, so we won't guess at one here. What we can say plainly is that, since 2024, Haiti's registration bureaucracy has in practice taken a back seat to a physical security and logistics crisis: with gangs controlling an estimated 80-90% of Port-au-Prince and the capital's main port terminal disrupted since a September 2024 attack, international health agencies have called for measures like secured air-bridges and temporary customs-formality waivers just to keep medical supplies moving. A serious injectable manufacturer in Haiti's supply chain today has to plan around both regulatory requirements and this security reality at the same time.
Quality Systems Behind Every Batch We Ship to Haiti
Every batch leaving Farbe Firma's Gujarat facility for Haiti passes through the same analytical panel we apply globally. Identity, assay and related-substance testing run on validated HPLC and GC methods benchmarked against USP, BP, IP and EP monographs, Karl Fischer titration confirms residual moisture in lyophilized and powder-fill products, and every sterile lot undergoes sterility testing and bacterial endotoxin (LAL) testing, alongside sub-visible particulate counts, pH, osmolality and fill-volume verification. This is the same certificate-of-analysis and validation documentation that MSPP's DPM/MT reviewers expect to see referenced in a sanitary-registration dossier, and that we make available to humanitarian and NGO partners running their own technical vetting.
Stability data is generated under ICH Q1A(R2) long-term and accelerated conditions, with photostability assessed per ICH Q1B, so shelf-life claims hold up under Haiti's tropical climate and the realities of getting a shipment to its final destination. Historically, the Port International de Port-au-Prince was the country's primary gateway, but with gangs controlling most of the capital and the port disrupted since the September 2024 terminal attack, Cap-Haïtien in the north — a combined seaport and international airport just 5km apart, roughly 136km from Port-au-Prince — has become the more realistic routing option, served by carriers such as King Ocean and Antillean. We plan cold-chain packaging and shipment scheduling around that northern routing and around the possibility of air-bridge arrangements, rather than assuming Port-au-Prince access is available.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in Haiti for Global Buyers
Haiti's disease burden and current crisis together shape a specific, urgent kind of injectable demand. Maternal mortality is among the highest in the Americas — around 350 per 100,000 live births in the most recent PAHO estimate, with 846 maternal deaths recorded in 2023 alone — keeping oxytocics and injectable antibiotics essential wherever functioning maternity care still operates. A cholera epidemic resurging since mid-2024, worsened by fuel shortages that have disrupted water treatment, has driven sustained need for IV fluids and case-management injectables, while the broader trauma and critical-care burden associated with ongoing violence keeps demand high for injectable antibiotics and emergency-care formulations.
For humanitarian organizations, NGOs and the importers still able to operate in this environment, Farbe Firma also functions as a CDMO/CMO partner, offering private-label sterile injectables built on the same WHO-GMP, ISO Class 5 platform, with CTD/ACTD-format technical files ready to support both DPM/MT's sanitary-registration dossier and the technical due diligence that NGOs and multilateral health partners typically require. We prepare the Certificate of Pharmaceutical Product, WHO-GMP certificate and full technical file with the understanding that, because Haiti is not a Hague Apostille Convention member, these documents will need to move through full consular legalization rather than a faster apostille process — and we build that lead time into every Haiti timeline from the outset.
In practice, what determines whether a Haiti shipment actually reaches patients has less to do with manufacturing than with two things: legalization lead time, since there is no apostille shortcut, and realistic logistics planning that routes through Cap-Haïtien rather than assuming access to Port-au-Prince. Given the scale of the current crisis — gang control of most of the capital, a disrupted main port, and international calls for emergency air-bridges — we recommend that partners plan conservatively, build contingency time into every shipment, and treat their in-country or humanitarian-sector partner relationship as essential rather than a formality. Farbe Firma's export team factors that reality into every Haiti engagement rather than presenting a standard timeline that assumes normal conditions.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified injectable manufacturer for Haiti?
Yes. Farbe Firma is a WHO-GMP certified sterile injectable manufacturer based in Gujarat, India, operating ISO Class 5 aseptic filling lines and producing more than 100 injectable products for export to over 30 countries. Our documentation is organized in CTD and ACTD formats and adapted to support both MSPP's DPM/MT sanitary-registration dossier and the technical due diligence that NGOs and humanitarian partners typically require in Haiti.
How does injectable product registration actually work in Haiti?
Every pharmaceutical product must receive sanitary registration from the Direction de la Pharmacie, du Médicament et de la Médecine Traditionnelle (DPM/MT), part of the Ministère de la Santé Publique et de la Population (MSPP). The dossier includes clinical study information, toxicology data, a pharmaceutical certificate from the country of origin, and physical product samples; MSPP must issue a favorable opinion, and a separate import permit is required from the Ministry of Commerce and Industry.
Do we need a local partner or agent to sell injectables in Haiti?
Yes, and given the current security and logistics crisis, that partner's ability to navigate both regulatory requirements and physical distribution — including routing through Cap-Haïtien rather than Port-au-Prince — matters as much as their registration experience. Many buyers are also working through humanitarian and NGO channels alongside conventional commercial importers, and Farbe Firma prepares documentation usable in both contexts.
Which injectables are in strongest demand in Haiti?
Given Haiti's maternal mortality rate, among the highest in the Americas, oxytocics and injectable antibiotics for maternal health are in constant demand, alongside IV fluids and case-management injectables driven by the cholera epidemic resurging since mid-2024, and broader trauma and critical-care injectables linked to the country's security crisis. Farbe Firma's 100+ product range covers all of these categories.
What documentation and logistics considerations matter most for a Haiti launch?
Because Haiti is not a Hague Apostille Convention member, Certificates of Pharmaceutical Product and GMP certificates from India require full consular/embassy legalization, which takes longer than an apostille — build that into your timeline. On logistics, plan around Cap-Haïtien International Airport and its adjacent seaport rather than Port-au-Prince, whose main port terminal has been disrupted since a September 2024 gang attack, and build in contingency time given the pace of security-driven change on the ground.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments